血栓闭塞性脉管炎动物模型研究进展

中国药物警戒 ›› 2012, Vol. 9 ›› Issue (12): 731-733.

血栓闭塞性脉管炎动物模型研究进展

王懿^1,2, 孙蓉^1*

1 山东省中医药研究院,山东济南 250014；
2 山东中医药大学,山东济南 250355

收稿日期:2011-04-11 出版日期:2012-12-10 发布日期:2015-08-07
通讯作者: 孙蓉,女,研究员,博士后,博士生导师,中药药理与毒理。E-mail：sunrong107@163.com
作者简介:王懿,女,在读硕士,中药药理与毒理。
基金资助:
国家重大新药创制专项十一五计划中药新药研究开发关键技术课题（2009ZX09502~015）,山东省重大新药创制综合性大平台中药单元平台中药药理与毒理子平台建设（2009ZX09301-013）

Research Development on Animal Models of Thromboangiitis Obliterans

WANG Yi^{1, 2}, SUN Rong^1*

1 Shandong Research Academy of TCM, Shandong Jinan 250014, China;
2 Shandong University of Traditional Chinese Medicine, Shandong Jinan 250355, China

Received:2011-04-11 Online:2012-12-10 Published:2015-08-07

摘要/Abstract

摘要： 目的对血栓闭塞性脉管炎（thromboangiitis obliterans TAO）动物模型制备方法进行综述,以寻找更加适合临床实际的造模方法。方法对近20年国内外TAO造模方法相关文献进行整理、分析、归纳。结果在已有TAO造模方法中,大鼠是首选造模动物,烟草致敏、寒冻、注射TAO免疫复合物等造摸方法虽然成模率都较好,也各有优缺点;以股动脉注射月桂酸改进模型与临床病理变化更相吻合,也被广泛应用于药理学活性发现和药效评价中。结论针对TAO发病机制的造模方法目前鲜有报道。因此,在深入探讨TAO发病机制基础上的造模方法学研究与模型制备,是创新药物发现与新药药效评价的前提。

关键词: 血栓闭塞性脉管炎, 造模方法, 研究进展

Abstract: objective To summarize preparation methods of TAO in animals, and find a more suitable method of making model in clinical research. Methods The related references in recent 20 years both at home and abroad about model making methods of TAO were analyzed, collated and summarized. Results In all the methods, rats were the first selected animal, and the methods of tobacco sensitization, cold aspic, injecting immune complex of TAO were better for making models, but each method had its merits and demerits. Method of injecting lauric acid into atreira cruralis without ZT viscose final encapsulation was most related to the clinical pathological changes, and was widely used in the research on pharmacology activity and efficacy evaluation. Conclusion The research on model making methods related with pathogenesis of TAO was rarely reported. So the research on methodology of model making related with the pathogenesis of TAO should be explored deeply, and that was the premise in discovery of innovation drug and evaluation of new drug efficacy.

Key words: thromboangiitis obliterans, method of making model, research development

王懿, 孙蓉. 血栓闭塞性脉管炎动物模型研究进展[J]. 中国药物警戒, 2012, 9(12): 731-733.

WANG Yi, SUN Rong. Research Development on Animal Models of Thromboangiitis Obliterans[J]. Chinese Journal of Pharmacovigilance, 2012, 9(12): 731-733.

参考文献

[1] 李德明,孔繁林.用免疫学方法复制成功一例血栓闭塞性脉管炎动物模型[J].中华实验外科杂志,1986,2(3):74-76.
[2] 陈锋,李占玲,吕延伟.脉痛宁胶囊治疗Ⅱ期血栓闭塞性脉管炎疼痛的实验研究[J].现代中西医结合杂志,2005,14(12):1550-
1554.
[3] 杨文涛,金星.血栓闭塞性脉管炎实验研究进展[J].中国中西医结合外科杂志,2000,6(4):306-308.
[4] 郭轶,代远斌.血栓闭塞性脉管炎发病机制的研究进展.重庆医科大学学报,2007,32:176-180.
[5] 张大伟,杨咏梅,金星,等.血栓闭塞性脉管炎大鼠模型的建立[J].上海实验动物科学,2003,23(4):203-206.
[6] 金星,张大伟,孟红,等.血栓闭塞性脉管炎动物模型的初步研究[J].山东中医药大学学报,2001,25(6):456-460.
[7] 冯友贤.血管外科学[M].第2版.上海:上海科学技术出版社,1992:296-297.
[8] 刘莉,韩静,王玮,等.血栓闭塞性脉管炎的中医药研究[J].文献研究,2009,8:41.
[9] 李仪奎,王钦茂,周金黄,等.中药药理实验方法学[J].上海:上海科学技术出版社,145.
[10] 沈成兴,梁春,陈良龙,等.经冠状动脉内注射月桂酸钠构建大鼠冠状动脉微栓塞模型[J].中国动脉硬化杂志,2005,13(4):447-450.
[11] 周晓辉,刘忠德,朱晓男,等.血栓闭塞性脉管炎造模方法的改进[J].辽宁中医杂志,2000,27(8):378-379.
[12] 周青,贺菊乔,曹晖,等.脉管通胶囊对血栓闭塞性脉管炎大鼠模型影响的研究[J].湖南中医学院学报,2003,8(23):4-7.
[13] 王军,王玉升,陈国华,等.脉络通冲剂抗血栓闭塞性脉管炎的实验研究[J].中国中西医结合杂志,1996,16(7):421-423.
[14] 苗智如,黄夏琴,程晓莉,等.注射用脉络宁对大鼠血栓闭塞性脉管炎模型的治疗作用[J].中药材,2008,31(6):880-882.
[15] O lin J W. Thromboangiitis obliterans(Buergers'disease)[J].N En-gl JM ed,2000,343(12):864-869.
[16] Puéchal X, Fiessinger JN.Thromboangiitis obliterans or Buerger 's disease challenges for the rheumatologist[J].Rheumatology(Ox-ford),2007,46(2):192-199.
[17] Malecki R,ZdrojowyK, Adamiec R.Thromboangiitis obliterans in the 21st century-a new face of disease[J].Atherosclerosis,2009,
206(2):328-334.
[18] 周晓辉,韩蕾.血栓闭塞性脉管炎的免疫学研究进展[J].辽宁中医杂志,1999,26(3):134.
[19] Edo N,M iyai K,Ogata S,et al.Thromboangiitis obliterans with multiple large vessel involvement case reportand analysis of immu-nophenotypes[J].Cardiovasc Pathol,2009,19(1):59-62.
[20] PapaM, BassA, AdarR, et al.Automimunemechanisms in thromboangiitis obliterans(Buergers' disease): the role oftobacco antigen and thema-jor histocompatibility complex[J].Surgery,1992,111(5):527-531.
[21] A rkkila P E.Thromboangiitis obliterans(Buerger 's disease)[J].Orphanet JRare Dis,2006,23(1):14.
[22] 傅益群,吕健.动物模型与中医证候关系释义[J].中医药学刊,2004,22(9):1665-1666.